He Q, Cheng Z, Li Y, Xing X, et al. A biweekly DPP-4 inhibitor cofrogliptin monotherapy in Chinese patients with impaired glucose tolerance: A phase 2, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial. Diabetes Obes Metab 2025;27:965-975.
PMID: 39632416